Just out
Hydrocortisone in Severe Community-Acquired Pneumonia.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Mar 2023 – Oct 2025Where it's discussed
-
X / Twitter335 posts
-
News46 articles
-
Blogs11 articles
-
Bluesky5 posts
-
Facebook5 posts
-
YouTube4 videos
-
Reddit2 posts
AI synopsis
What people are saying
The digital discussions reflect diverse opinions on the research, with references to specific findings such as '6.2% of hydrocortisone group dead at 28 days vs. 11.9% in the placebo group.' Phrases like 'may pose potential harm' indicate a cautious tone, while others refer to it as 'highly beneficial' for ICU patients, demonstrating the contrasting attitudes towards hydrocortisone's use in treatment. This variability in tone and perspective showcases the complex nature of clinical research interpretation.
While there is a lack of clear consensus, some discussions express skepticism about the publication's findings, indicating mixed opinions on hydrocortisone's efficacy.
The posts reveal high interest in the topic, with many users actively sharing their thoughts and links to the article, evidenced by references and commentary on the trial.
Users engage at a moderate depth, with discussions including specific trial results and opposing viewpoints, showing some critical thinking on the topic.
There is a perception of moderate impact, as users recognize the publication's potential implications for treatment protocols, though some express caution regarding its applicability.
Abstract in brief
- A phase 3 clinical trial investigated if intravenous hydrocortisone could reduce mortality in patients with severe community-acquired pneumonia compared to a placebo.
- The study involved 800 patients, and results showed that those receiving hydrocortisone had a significantly lower death rate (6.2%) at 28 days versus 11.9% in the placebo group.
- Additionally, patients on hydrocortisone required less mechanical ventilation and vasopressors compared to those on placebo, with similar rates of hospital-acquired infections and bleeding risks.
Top posts
Most liked on X and BlueskyCAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquired Pneumonia. NEJM (2023). Cápsula 419. https://t.co/YS6zWNLfFJ https://t.co/evp9CwwsMm
NEJMより,重症市中肺炎へのステロイド投与についての多施設RCT(n=795). 肺炎でICU入室した成人(septic shockは除外)を,ステロイド(ヒドロコルチゾン静注200mg/日を4or8日間)投与群とプラセボ群に割付. 28日時点での死亡率はステロイド群の方が有意に低かった(6.2%vs11.9%). https://t.co/cjHwqDnPFz
CAPE COD simple design RCT >700 pts published @NEJM hydrocortisone is highly beneficial in CAP managed in the ICU @GiacomoMonti @alessanro_pruna @CritCareReviews Hydrocortisone in Severe Community-Acquired Pneumonia NEJM https://t.co/qeRujwRd5Z
ICUに入室した成人重症市中肺炎に対するヒドロコルチゾン(200mg/日→漸減)投与はプラセボに比して28日死亡を有意に改善させた(6.2%vs11.9%).新たに人工呼吸器装着や血管作動薬を要した患者も有意に少なかった.800例DB-RCT,PhaseⅢ(N Engl J Med 2023 Mar21) https://t.co/wP5SpMs8Ws
HIDROCORTISONA reduce de forma muy relevante la mortalidad en pneumonía (NAC) en UCI. Metilprednisolona, mucho más glucocorticoide, no lo había conseguido. Puede ser "huérfano secundario" por falta de interés económico. FH puede tener un papel importante. https://t.co/OMbEWOpz3N
All mentions
Hydrocortisone Reduces Mortality by 48% in Severe Community-Acquired Pneumonia
Hydrocortisone's Impact on Severe Community-Acquired Pneumonia
This video explores a phase 3 clinical trial evaluating the effects of intravenous hydrocortisone on mortality in patients with severe community-acquired pneumonia. Results indicated a significantly lower death rate at…
Hydrocortisone Reduces Mortality in Severe Pneumonia Patients
A phase 3 clinical trial investigated if intravenous hydrocortisone could reduce mortality in patients with severe community-acquired pneumonia. Results showed a significantly lower death rate in the hydrocortisone…
Community Acquired Pneumonia: Diagnosis and Treatment Insights
One of the most common diagnoses is community acquired pneumonia (CAP). This video covers the pathogenesis, diagnostic workup, and treatment options. We also highlight new findings on hydrocortisone's role in severe…
#1minutevideo A 7-day course of hydrocortisone in severe community-acquired pneumonia was unlikely to reduce 90-day mortality and may pose potential harm, despite a possible reduction in shock duration. zurl.co/95rMB
#VisualAbstract A 7-day course of hydrocortisone in severe community-acquired pneumonia was unlikely to reduce 90-day mortality and may pose potential harm, despite a possible reduction in shock duration. zurl.co/Z9lKj
RT @MedClubPage: #Infectología #MedicinaCrítica El uso de Hidrocortisona en pacientes con neumonía severa sin choque séptico se asoció a me…
https://t.co/e7GqtTsH6e
A 7-day course of hydrocortisone in severe community-acquired pneumonia was unlikely to reduce 90-day mortality and may pose potential harm, despite a possible reduction in shock duration. zurl.co/fdgUc
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
RT @ProfJDChalmers: Just out
Just out
@RWMaloneMD @SenBillCassidy bad pneumonia, especially in a life threatening situation. Malone you are a disgrace to the profession. See attached article on IV steroids and pneumonia, note it was published in the NEJM https://t.co/XQCasfzvUl
RT @IM_Crit_: Thanks for reading! Kudos to the authors! DOI: 10.1001/jama.2015.88 DOI: 10.1056/NEJMoa2215145 https://t.co/itdseQtyjN
RT @IM_Crit_: Thanks for reading! Kudos to the authors! DOI: 10.1001/jama.2015.88 DOI: 10.1056/NEJMoa2215145 https://t.co/itdseQtyjN
RT @IM_Crit_: Thanks for reading! Kudos to the authors! DOI: 10.1001/jama.2015.88 DOI: 10.1056/NEJMoa2215145 https://t.co/itdseQtyjN
重症市中肺炎へのヒドロコルチゾンは死亡率を有意に低下させた- 亀田メディカルセンター おフランス
RT @IM_Crit_: Thanks for reading! Kudos to the authors! DOI: 10.1001/jama.2015.88 DOI: 10.1056/NEJMoa2215145 https://t.co/itdseQtyjN
Thanks for reading! Kudos to the authors! DOI: 10.1001/jama.2015.88 DOI: 10.1056/NEJMoa2215145 https://t.co/itdseQtyjN
DOI: 10.1001/jama.2015.88 DOI: 10.1056/NEJMoa2215145 #foamed #foamcc #meded #medsky #emimcc #cccsky #idsky
RT @CritCareReviews: Hydrocortisone in Severe Community-Acquired Pneumonia ➡️ 800 pts ➡️ IV hydrocortisone 200 mg daily for 4 or 8 days or…
@nickmmark @DrToddLee @NEJM @arorashMD https://t.co/DcEg9IOzmd https://t.co/TC6od2QM3Y
It's Day 6 of #RespMas! Behind today's #advent window is @nejm paper from 2023 by Dequin et al Hydrocortisone in Severe Community-Acquired Pneumonia which found in favour of using iv hydrocortisone in severe CAP in ICU www.nejm.org/doi/full/10.... #medsky #RespEd #pulmsky #lungsky
@SeeFisch https://t.co/qEKuhb8zjd
RT @NEJM: Year in Review: Top 10
RT @IM_Crit_: @ProStatusQuo Something along these lines: https://t.co/SwuVAUYLqU
@ProStatusQuo Something along these lines: https://t.co/SwuVAUYLqU
RT @KingsResp: @NICEComms @WHO @BTSrespiratory In the CAPE COD trial authors reported a significant decrease in mortality, with 6.2% of th…
@NICEComms @WHO @BTSrespiratory In the CAPE COD trial authors reported a significant decrease in mortality, with 6.2% of the hydrocortisone group, 11.9% of the placebo group dead at 28 days (absolute difference −5.6% [95%CI: −9.6 to −1.7%], p = 0.006). https://t.co/oIFyHeoMt9 @NEJM 10/n #RespEd
@KingsResp B. Hydrocortisone 200mg daily for 4-7 days. DOI: 10.1056/NEJMoa2215145
RT @MikeMcNealMD: Hydrocortisone in Severe Community Acquired pneumonia. Lower risk of death in the first 30 days. @mettingal #BSWIMRPadre…
Hydrocortisone in Severe Community Acquired pneumonia. Lower risk of death in the first 30 days. @mettingal #BSWIMRPadre2024 #BSWHTemple_IMED https://t.co/JSoEDbg4xm
RT @giovannilandoni: CAPE COD simple design RCT >700 pts published @NEJM hydrocortisone is highly beneficial in CAP managed in the ICU @…
RT @giovannilandoni: CAPE COD simple design RCT >700 pts published @NEJM hydrocortisone is highly beneficial in CAP managed in the ICU @…
RT @giovannilandoni: CAPE COD simple design RCT >700 pts published @NEJM hydrocortisone is highly beneficial in CAP managed in the ICU @…
RT @giovannilandoni: CAPE COD simple design RCT >700 pts published @NEJM hydrocortisone is highly beneficial in CAP managed in the ICU @…
RT @giovannilandoni: CAPE COD simple design RCT >700 pts published @NEJM hydrocortisone is highly beneficial in CAP managed in the ICU @…
RT @giovannilandoni: CAPE COD simple design RCT >700 pts published @NEJM hydrocortisone is highly beneficial in CAP managed in the ICU @…
RT @giovannilandoni: CAPE COD simple design RCT >700 pts published @NEJM hydrocortisone is highly beneficial in CAP managed in the ICU @…
RT @MMarmiere: @remap_cap steroid results are in contrast with CAPE COD
RT @MMarmiere: @remap_cap steroid results are in contrast with CAPE COD
RT @giovannilandoni: CAPE COD simple design RCT >700 pts published @NEJM hydrocortisone is highly beneficial in CAP managed in the ICU @…
@remap_cap steroid results are in contrast with CAPE COD
RT @giovannilandoni: CAPE COD simple design RCT >700 pts published @NEJM hydrocortisone is highly beneficial in CAP managed in the ICU @…
CAPE COD simple design RCT >700 pts published @NEJM hydrocortisone is highly beneficial in CAP managed in the ICU @GiacomoMonti @alessanro_pruna @CritCareReviews Hydrocortisone in Severe Community-Acquired Pneumonia NEJM https://t.co/qeRujwRd5Z
Link al paper del CAPE-COP Trial presentado en #ATS2024
Hydrocortisone helps reduce mortality in CAP - Cape COD study Dr Anica Law #ATS2024 https://t.co/4CjrjkIZ6W https://t.co/Ji6zWdUKTd
RT @JHospMedicine: How could we not make a VA for JHM's own @SuchitaSata @zahirkanjee
RT @JHospMedicine: How could we not make a VA for JHM's own @SuchitaSata @zahirkanjee
RT @JHospMedicine: How could we not make a VA for JHM's own @SuchitaSata @zahirkanjee
RT @JHospMedicine: First #UpdatesInHM Article for #SHMConverge24:
RT @JHospMedicine: How could we not make a VA for JHM's own @SuchitaSata @zahirkanjee
RT @JHospMedicine: How could we not make a VA for JHM's own @SuchitaSata @zahirkanjee
RT @JHospMedicine: How could we not make a VA for JHM's own @SuchitaSata @zahirkanjee
RT @JHospMedicine: How could we not make a VA for JHM's own @SuchitaSata @zahirkanjee
RT @JHospMedicine: How could we not make a VA for JHM's own @SuchitaSata @zahirkanjee
How could we not make a VA for JHM's own @SuchitaSata @zahirkanjee
RT @JHospMedicine: First #UpdatesInHM Article for #SHMConverge24:
RT @JHospMedicine: First #UpdatesInHM Article for #SHMConverge24:
RT @JHospMedicine: First #UpdatesInHM Article for #SHMConverge24:
RT @JHospMedicine: First #UpdatesInHM Article for #SHMConverge24:
First #UpdatesInHM Article for #SHMConverge24:
@Denis_Faust Le papier: https://t.co/yh0roVgluw Il est intégré depuis qq mois dans le protocoles sur le blogs, de fait: https://t.co/fhKxMav3oe Il est intégré aux reco SPLF 2024: https://t.co/NmVpme8wHS Ça ne concerne que les patients sévères (surtout urgence/réa).
@linternedes_urg @Rhazelovitch 200mg/j pendant 4-7 jours. https://t.co/cZ8XalgnmO
RT @im_rockstars: Guidelines now suggest steroids in severe CAP (ie ICU patients). CAP ICU pts treated with IV hydrocort absolute risk of…
Are steroids useful? Yes for severe CAP in ICU, acute bacterial meningitis, What else? https://t.co/QpeFqIGsEI
RT @EmilioAlegre1: HIDROCORTISONA reduce de forma muy relevante la mortalidad en pneumonía (NAC) en UCI. Metilprednisolona, mucho más gluco…
RT @EmilioAlegre1: HIDROCORTISONA reduce de forma muy relevante la mortalidad en pneumonía (NAC) en UCI. Metilprednisolona, mucho más gluco…
RT @EmilioAlegre1: HIDROCORTISONA reduce de forma muy relevante la mortalidad en pneumonía (NAC) en UCI. Metilprednisolona, mucho más gluco…
Guidelines now suggest steroids in severe CAP (ie ICU patients). CAP ICU pts treated with IV hydrocort absolute risk of ☠️ 5.6%⏬️ at 28d. Steroids may modulate
@gustavommm75 @nickmmark @Crit_Care this was only an example of critical care study which was stopped early for efficacy… but the topic is hot and signals are accumulating … https://t.co/qeRujwRd5Z
@nickmmark Cape Cod! https://t.co/8xLXBRhh4j
Entre 795 pacientes graves con Neumonía Adquirida en la Comunidad se probó la administración de Hidrocortisona y hubo fallecidos en 25/400 vs. 47/395, intubación endotraqueal en 40/222 vs. 65/220, uso de vasopresores en 55/359 vs. 86/344 al día 28. https://t.co/VGtqhdySJe
Discover the latest findings in our Literature Review on Hydrocortisone use in Severe Community-Acquired Pneumonia. Get a glimpse with this snippet.
RT @EmilioAlegre1: HIDROCORTISONA reduce de forma muy relevante la mortalidad en pneumonía (NAC) en UCI. Metilprednisolona, mucho más gluco…
RT @EmilioAlegre1: HIDROCORTISONA reduce de forma muy relevante la mortalidad en pneumonía (NAC) en UCI. Metilprednisolona, mucho más gluco…
RT @EmilioAlegre1: HIDROCORTISONA reduce de forma muy relevante la mortalidad en pneumonía (NAC) en UCI. Metilprednisolona, mucho más gluco…
RT @EmilioAlegre1: HIDROCORTISONA reduce de forma muy relevante la mortalidad en pneumonía (NAC) en UCI. Metilprednisolona, mucho más gluco…
RT @EmilioAlegre1: HIDROCORTISONA reduce de forma muy relevante la mortalidad en pneumonía (NAC) en UCI. Metilprednisolona, mucho más gluco…
RT @EmilioAlegre1: HIDROCORTISONA reduce de forma muy relevante la mortalidad en pneumonía (NAC) en UCI. Metilprednisolona, mucho más gluco…
RT @EmilioAlegre1: HIDROCORTISONA reduce de forma muy relevante la mortalidad en pneumonía (NAC) en UCI. Metilprednisolona, mucho más gluco…
RT @EmilioAlegre1: HIDROCORTISONA reduce de forma muy relevante la mortalidad en pneumonía (NAC) en UCI. Metilprednisolona, mucho más gluco…
RT @EmilioAlegre1: HIDROCORTISONA reduce de forma muy relevante la mortalidad en pneumonía (NAC) en UCI. Metilprednisolona, mucho más gluco…
RT @EmilioAlegre1: HIDROCORTISONA reduce de forma muy relevante la mortalidad en pneumonía (NAC) en UCI. Metilprednisolona, mucho más gluco…
RT @EmilioAlegre1: HIDROCORTISONA reduce de forma muy relevante la mortalidad en pneumonía (NAC) en UCI. Metilprednisolona, mucho más gluco…
RT @EmilioAlegre1: HIDROCORTISONA reduce de forma muy relevante la mortalidad en pneumonía (NAC) en UCI. Metilprednisolona, mucho más gluco…
RT @EmilioAlegre1: HIDROCORTISONA reduce de forma muy relevante la mortalidad en pneumonía (NAC) en UCI. Metilprednisolona, mucho más gluco…
RT @EmilioAlegre1: HIDROCORTISONA reduce de forma muy relevante la mortalidad en pneumonía (NAC) en UCI. Metilprednisolona, mucho más gluco…
HIDROCORTISONA reduce de forma muy relevante la mortalidad en pneumonía (NAC) en UCI. Metilprednisolona, mucho más glucocorticoide, no lo había conseguido. Puede ser "huérfano secundario" por falta de interés económico. FH puede tener un papel importante. https://t.co/OMbEWOpz3N
RT @LandmarkTrials: In patients with severe pneumonia requiring ICU care, those who received hydrocortisone had a lower risk of death as we…
RT @vm_aventho: HIDROCORTISONA EN NEUMONÍA GRAVE ADQUIRIDA EN LA COMUNIDAD: “Va de nuevo” CRITERIOS DE NEUMONÍA GRAVE EN ESTE ESTUDIO (CAPE…
RT @vm_aventho: HIDROCORTISONA EN NEUMONÍA GRAVE ADQUIRIDA EN LA COMUNIDAD: “Va de nuevo” CRITERIOS DE NEUMONÍA GRAVE EN ESTE ESTUDIO (CAPE…
RT @vm_aventho: HIDROCORTISONA EN NEUMONÍA GRAVE ADQUIRIDA EN LA COMUNIDAD: “Va de nuevo” CRITERIOS DE NEUMONÍA GRAVE EN ESTE ESTUDIO (CAPE…
RT @vm_aventho: HIDROCORTISONA EN NEUMONÍA GRAVE ADQUIRIDA EN LA COMUNIDAD: “Va de nuevo” CRITERIOS DE NEUMONÍA GRAVE EN ESTE ESTUDIO (CAPE…
RT @vm_aventho: HIDROCORTISONA EN NEUMONÍA GRAVE ADQUIRIDA EN LA COMUNIDAD: “Va de nuevo” CRITERIOS DE NEUMONÍA GRAVE EN ESTE ESTUDIO (CAPE…
RT @vm_aventho: HIDROCORTISONA EN NEUMONÍA GRAVE ADQUIRIDA EN LA COMUNIDAD: “Va de nuevo” CRITERIOS DE NEUMONÍA GRAVE EN ESTE ESTUDIO (CAPE…
RT @vm_aventho: HIDROCORTISONA EN NEUMONÍA GRAVE ADQUIRIDA EN LA COMUNIDAD: “Va de nuevo” CRITERIOS DE NEUMONÍA GRAVE EN ESTE ESTUDIO (CAPE…
RT @vm_aventho: HIDROCORTISONA EN NEUMONÍA GRAVE ADQUIRIDA EN LA COMUNIDAD: “Va de nuevo” CRITERIOS DE NEUMONÍA GRAVE EN ESTE ESTUDIO (CAPE…
RT @vm_aventho: HIDROCORTISONA EN NEUMONÍA GRAVE ADQUIRIDA EN LA COMUNIDAD: “Va de nuevo” CRITERIOS DE NEUMONÍA GRAVE EN ESTE ESTUDIO (CAPE…
RT @vm_aventho: HIDROCORTISONA EN NEUMONÍA GRAVE ADQUIRIDA EN LA COMUNIDAD: “Va de nuevo” CRITERIOS DE NEUMONÍA GRAVE EN ESTE ESTUDIO (CAPE…
RT @vm_aventho: HIDROCORTISONA EN NEUMONÍA GRAVE ADQUIRIDA EN LA COMUNIDAD: “Va de nuevo” CRITERIOS DE NEUMONÍA GRAVE EN ESTE ESTUDIO (CAPE…
重度の市中肺炎におけるヒドロコルチゾン | NEJM https://t.co/FtePttthxY
RT @vm_aventho: HIDROCORTISONA EN NEUMONÍA GRAVE ADQUIRIDA EN LA COMUNIDAD: “Va de nuevo” CRITERIOS DE NEUMONÍA GRAVE EN ESTE ESTUDIO (CAPE…
RT @vm_aventho: HIDROCORTISONA EN NEUMONÍA GRAVE ADQUIRIDA EN LA COMUNIDAD: “Va de nuevo” CRITERIOS DE NEUMONÍA GRAVE EN ESTE ESTUDIO (CAPE…
RT @vm_aventho: HIDROCORTISONA EN NEUMONÍA GRAVE ADQUIRIDA EN LA COMUNIDAD: “Va de nuevo” CRITERIOS DE NEUMONÍA GRAVE EN ESTE ESTUDIO (CAPE…
RT @vm_aventho: HIDROCORTISONA EN NEUMONÍA GRAVE ADQUIRIDA EN LA COMUNIDAD: “Va de nuevo” CRITERIOS DE NEUMONÍA GRAVE EN ESTE ESTUDIO (CAPE…
RT @vm_aventho: HIDROCORTISONA EN NEUMONÍA GRAVE ADQUIRIDA EN LA COMUNIDAD: “Va de nuevo” CRITERIOS DE NEUMONÍA GRAVE EN ESTE ESTUDIO (CAPE…
RT @YukiKotani5: 多施設RCT:CAPE COD trial @NEJM https://t.co/ldquLaXbYc
多施設RCT:CAPE COD trial @NEJM https://t.co/ldquLaXbYc
RT @vm_aventho: HIDROCORTISONA EN NEUMONÍA GRAVE ADQUIRIDA EN LA COMUNIDAD: “Va de nuevo” CRITERIOS DE NEUMONÍA GRAVE EN ESTE ESTUDIO (CAPE…
RT @vm_aventho: HIDROCORTISONA EN NEUMONÍA GRAVE ADQUIRIDA EN LA COMUNIDAD: “Va de nuevo” CRITERIOS DE NEUMONÍA GRAVE EN ESTE ESTUDIO (CAPE…
RT @vm_aventho: HIDROCORTISONA EN NEUMONÍA GRAVE ADQUIRIDA EN LA COMUNIDAD: “Va de nuevo” CRITERIOS DE NEUMONÍA GRAVE EN ESTE ESTUDIO (CAPE…
RT @vm_aventho: HIDROCORTISONA EN NEUMONÍA GRAVE ADQUIRIDA EN LA COMUNIDAD: “Va de nuevo” CRITERIOS DE NEUMONÍA GRAVE EN ESTE ESTUDIO (CAPE…
RT @vm_aventho: HIDROCORTISONA EN NEUMONÍA GRAVE ADQUIRIDA EN LA COMUNIDAD: “Va de nuevo” CRITERIOS DE NEUMONÍA GRAVE EN ESTE ESTUDIO (CAPE…
RT @vm_aventho: HIDROCORTISONA EN NEUMONÍA GRAVE ADQUIRIDA EN LA COMUNIDAD: “Va de nuevo” CRITERIOS DE NEUMONÍA GRAVE EN ESTE ESTUDIO (CAPE…
RT @vm_aventho: HIDROCORTISONA EN NEUMONÍA GRAVE ADQUIRIDA EN LA COMUNIDAD: “Va de nuevo” CRITERIOS DE NEUMONÍA GRAVE EN ESTE ESTUDIO (CAPE…
RT @vm_aventho: HIDROCORTISONA EN NEUMONÍA GRAVE ADQUIRIDA EN LA COMUNIDAD: “Va de nuevo” CRITERIOS DE NEUMONÍA GRAVE EN ESTE ESTUDIO (CAPE…
Hydrocortisone in Severe Community-Acquired Pneumonia | NEJM https://t.co/CVKWzu1qQx
RT @giovannilandoni: 2/15 #Hydrocortisone in 800 severe community-acquired pneumonia reduced the risk of death by day 28 @NEJM https://t…
RT @giovannilandoni: 2/15 #Hydrocortisone in 800 severe community-acquired pneumonia reduced the risk of death by day 28 @NEJM https://t…
RT @giovannilandoni: 2/15 #Hydrocortisone in 800 severe community-acquired pneumonia reduced the risk of death by day 28 @NEJM https://t…
Hydrocortisone in Severe Community-Acquired Pneumonia | NEJM https://t.co/P4Q9090WiQ
RT @giovannilandoni: 2/15 #Hydrocortisone in 800 severe community-acquired pneumonia reduced the risk of death by day 28 @NEJM https://t…
3/8 - Early Active Mobilization during Mechanical Ventilation in the ICU https://t.co/EfX44x9iBj - Extracorporeal Life Support in Infarct-Related Cardiogenic Shock https://t.co/YCXj3VF4OW - Hydrocortisone in Severe Community-Acquired Pneumonia https://t.co/xcDkhFslnE
2/15 #Hydrocortisone in 800 severe community-acquired pneumonia reduced the risk of death by day 28 @NEJM https://t.co/KtDbJlbO1D
No. 8 :Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity (STEP-HFpEF) : https://t.co/8pcGMY4SYW No. 9 :Hydrocortisone in Severe Community-Acquired Pneumonia (CRICS-TriGGERSep) : https://t.co/gF21ikjEbI
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
@ZhouHang2020 @NEJM Saved! Here's the compiled thread: https://t.co/1Bs7OgFhIt
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
RT @NEJM: Year in Review: Top 10
2. Dequin P-F, Meziani F, Quenot J-P, Kamel T, Ricard J-D, Badie J, et al. Hydrocortisone in severe community-acquired pneumonia. N Engl J Med [Internet]. 2023 [citado el 30 de octubre de 2023];388(21):1931–41. Disponible en: https://t.co/qomvUJf1nh
RT @OrlandoRPN: Hidrocortisona en Neumonía Grave (adquirida en la comunidad) logró disminuir la mortalidad ✅ Px que mejoraron al día 4: 20…
CAPE-COD was published this year and is the largest trial included. It reported for a hydrocortisone regimen there was a reduction in 28 day mortality.
@BradSpellberg @jpogue1 @DrToddLee https://t.co/glBM0e25f0 https://t.co/WTDUpTspxk
重篤な市中肺炎におけるヒドロコルチゾン(RCT) https://t.co/UFngP0L9Yx #JCメモ
https://t.co/AL7NOwb7fp
Hydrocortisone in Severe Community-Acquired Pneumonia - PubMed https://t.co/6dBXaytWWn
Hydrocortisone in Severe Community-Acquired Pneumonia | NEJM https://t.co/IHx0XGTfyL
RT @KessnerJp: Hydrocortisone in Severe Community-Acquired Pneumonia. https://t.co/OntsD91nsA
#CPPPLU Highlights: The CAPE COD trial examined the impact of IV hydrocortisone added to standard of care for severe community-acquired pneumonia. They found a 5.6% reduction in 28-day mortality and no difference in adverse events @NEJM #PharmICU https://t.co/L8pqDMaEFu
@frantait85 @Lucie_911 Seconded https://t.co/J4jPZykQ6y
https://t.co/wnFc4mgeeH
Next
#SCCMJC #PharmICU Presenter 3: Austin Roe @ausroe, PharmD PGY2 CC Johnson City Medical Center Hydrocortisone in severe community-acquired pneumonia @NEJM https://t.co/L8pqDMaEFu
Hydrocortisone in Severe Community-Acquired Pneumonia | NEJM https://t.co/8X96TaGD3k
How will the recently published CAPE COD trial change your corticosteroid use in ICU patients with CAP? https://t.co/zluZ1h8oMa
RT @docalok: @iapindia @UKinjawadekar @AdolHealthIAP @EnvironChildIAP @DrBakulParekh @dr_soans @ProfSomashekhar @naveenthacker @DrMariaNeir…
RT @docalok: @iapindia @UKinjawadekar @AdolHealthIAP @EnvironChildIAP @DrBakulParekh @dr_soans @ProfSomashekhar @naveenthacker @DrMariaNeir…
RT @IcuCast: CAPECOD is a positive study of steroids in severe CAP, but what does @toddrice_ICU call "corn" on? How does @edqian define "wi…
@aymanalameer7 @waleedalhazzani https://t.co/1mNlWi5R8e
RT @SCCM_CPP: #SCCMJC #PharmICU Presenter 3: Austin Roe @ausroe, PharmD PGY2 CC Johnson City Medical Center Hydrocortisone in severe com…
#SCCMJC #PharmICU Presenter 3: Austin Roe @ausroe, PharmD PGY2 CC Johnson City Medical Center Hydrocortisone in severe community-acquired pneumonia @NEJM https://t.co/L8pqDMaEFu
(5) ESCAPe and Santeon-CAP saw no benefit of corticosteroids (in line with prior studies) and then Dequin et al was published — where the benefit was found in those with hyper inflammation similar to COVID (CRP > 15 mg/dL, Figure S3) https://t.co/VWbdf6AZjn
RT @docalok: @iapindia @UKinjawadekar @AdolHealthIAP @EnvironChildIAP @DrBakulParekh @dr_soans @ProfSomashekhar @naveenthacker @DrMariaNeir…
ICU入室重症市中肺炎のハイドロコルチゾン使用のランダム化比較試験でハイドロコルチゾン投与群がプラセボに比べ28日死亡率、気管内挿管必要比率、vasopressor必要率いずれも改善した。院内感染、消化管出血は差を認めず。https://t.co/IWOmaChi6p
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @donsin4: Really useful recommendations from a Task Force on management of #severe #pneumonia. The best I've seen in years. The only thi…
RT @donsin4: Really useful recommendations from a Task Force on management of #severe #pneumonia. The best I've seen in years. The only thi…
RT @donsin4: Really useful recommendations from a Task Force on management of #severe #pneumonia. The best I've seen in years. The only thi…
RT @donsin4: Really useful recommendations from a Task Force on management of #severe #pneumonia. The best I've seen in years. The only thi…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @donsin4: Really useful recommendations from a Task Force on management of #severe #pneumonia. The best I've seen in years. The only thi…
Really useful recommendations from a Task Force on management of #severe #pneumonia. The best I've seen in years. The only thing I would quibble with is the earlier use of #hydrocortisone with severe pneumonia (https://t.co/o3eqHKfCYz) https://t.co/vjnRmvLBQW https://t.co/YF6EXr7VAG
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @docalok: @iapindia @UKinjawadekar @AdolHealthIAP @EnvironChildIAP @DrBakulParekh @dr_soans @ProfSomashekhar @naveenthacker @DrMariaNeir…
@iapindia @UKinjawadekar @AdolHealthIAP @EnvironChildIAP @DrBakulParekh @dr_soans @ProfSomashekhar @naveenthacker @DrMariaNeira @IPAWorldorg @DocAlokGupta @samyrdalwai @Asiapacific_Ped @amanpulungan @BanLeadPaint @BanFossilFuel https://t.co/OwSIuKtlO7
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
Glucocorticoids can improve survival for severe community-acquired pneumonia | NEJM https://t.co/xkexD0aUOD
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @OLOLanaesthesia: Steroids should be strongly considered in patients admitted with severe CAP. https://t.co/yhxTVIyChb
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
RT @capsulas_de: CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquire…
CAPE COD ClinicalTrials: Hidrocortisona en neumonía comunitaria grave… Fuente: Hydrocortisone in Severe Community-Acquired Pneumonia. NEJM (2023). Cápsula 419. https://t.co/YS6zWNLfFJ https://t.co/evp9CwwsMm
RT @ucsdpccm: Thank you Alisha Kabadi (#pccm fellow) for presenting Hydrocortisone in Severe Community-Acquired Pneumonia in @NEJM! https…
Steroids should be strongly considered in patients admitted with severe CAP. https://t.co/yhxTVIyChb
RT @ucsdpccm: Thank you Alisha Kabadi (#pccm fellow) for presenting Hydrocortisone in Severe Community-Acquired Pneumonia in @NEJM! https…
RT @ucsdpccm: Thank you Alisha Kabadi (#pccm fellow) for presenting Hydrocortisone in Severe Community-Acquired Pneumonia in @NEJM! https…
RT @ucsdpccm: Thank you Alisha Kabadi (#pccm fellow) for presenting Hydrocortisone in Severe Community-Acquired Pneumonia in @NEJM! https…
RT @ucsdpccm: Thank you Alisha Kabadi (#pccm fellow) for presenting Hydrocortisone in Severe Community-Acquired Pneumonia in @NEJM! https…
Thank you Alisha Kabadi (#pccm fellow) for presenting Hydrocortisone in Severe Community-Acquired Pneumonia in @NEJM! https://t.co/h6DZ04ljtX #MedTwitter #MedEd https://t.co/80cm9Nmn2h
RT @IcuCast: CAPECOD is a positive study of steroids in severe CAP, but what does @toddrice_ICU call "corn" on? How does @edqian define "wi…
Just out in @NEJM : For patients with severe CAP admitted to ICU, addition of IV hydrocortisone 200 mg daily for 4 or 8 days to standard therapy (antibiotics, supportive care) improves 28 d mortality #MedTwitter https://t.co/omQX6MmamQ
https://t.co/mvMKy7H2oZ
結果:28日目までに死亡した患者はステロイド群で有意に少なかった。 結論:早期のステロイド投与は重症市中肺炎の28日以内の死亡率を減少させる。 N Engl J Med 2023; https://t.co/ItGMEHl6VQ. 10.1056/NEJMoa2215145
RT @PubTrend: Trending on PubMed: Hydrocortisone in Severe Community-Acquired Pneumonia. https://t.co/ajaotrFk6g
Trending on PubMed: Hydrocortisone in Severe Community-Acquired Pneumonia. https://t.co/ajaotrFk6g
RT @IcuCast: CAPECOD is a positive study of steroids in severe CAP, but what does @toddrice_ICU call "corn" on? How does @edqian define "wi…
RT @IcuCast: CAPECOD is a positive study of steroids in severe CAP, but what does @toddrice_ICU call "corn" on? How does @edqian define "wi…
RT @IcuCast: CAPECOD is a positive study of steroids in severe CAP, but what does @toddrice_ICU call "corn" on? How does @edqian define "wi…
RT @IcuCast: CAPECOD is a positive study of steroids in severe CAP, but what does @toddrice_ICU call "corn" on? How does @edqian define "wi…
Hydrocortisone in Severe Community-Acquired Pneumonia https://t.co/s2EzsZN2b8 結構話題になってた重症市中肺炎における治療開始時のHDC投与が退院後28日後の死亡率を改善したという報告。
RT @IcuCast: CAPECOD is a positive study of steroids in severe CAP, but what does @toddrice_ICU call "corn" on? How does @edqian define "wi…
RT @IcuCast: CAPECOD is a positive study of steroids in severe CAP, but what does @toddrice_ICU call "corn" on? How does @edqian define "wi…
RT @IcuCast: CAPECOD is a positive study of steroids in severe CAP, but what does @toddrice_ICU call "corn" on? How does @edqian define "wi…
CAPECOD is a positive study of steroids in severe CAP, but what does @toddrice_ICU call "corn" on? How does @edqian define "wildly positive"? Hear about this and more on ICU-Ed and Todd-cast! (https://t.co/rjPVmxdagw) CAPECOD: https://t.co/qKK7Yar9UT https://t.co/bja2HRoiMi
1/5 Interesting new
Very interesting RCT results on hydrocortisone treatment in severe pneumonia (adults). Would hydrocortisone be beneficial in sick children too? What say you, @RhedinSamuel ? https://t.co/5aQVe26EfV
およびプラセボ群で、それぞれ6.2%および11.9%の患者が死亡しました。この差は統計的に有意です。https://t.co/Mqjgc7Y32S
RT @FlightDocKosuke: NEJMより,重症市中肺炎へのステロイド投与についての多施設RCT(n=795). 肺炎でICU入室した成人(septic shockは除外)を,ステロイド(ヒドロコルチゾン静注200mg/日を4or8日間)投与群とプラセボ群に割付.…
Hydrocortisone in Severe Community-Acquired Pneumonia - PubMed ( Here goes the pendulum again ! We have been going back and forth through this since I was an IM resident in 1985! ) https://t.co/pzZpqZGHaC
RT @IcuCast: Episode 7 is out! We take a deep dive into steroids for community acquired pneumonia and talk about the CAPECOD trial publishe…
RT @IcuCast: Episode 7 is out! We take a deep dive into steroids for community acquired pneumonia and talk about the CAPECOD trial publishe…
RT @IcuCast: Episode 7 is out! We take a deep dive into steroids for community acquired pneumonia and talk about the CAPECOD trial publishe…
Episode 7 is out! We take a deep dive into steroids for community acquired pneumonia and talk about the CAPECOD trial published in @NEJM last week! Check us out wherever you get your podcasts: https://t.co/qPyhTM2Rd4 CAPECOD: https://t.co/qKK7YaqC5l
Pneumopathie sévère. Hydrocortisone
@NikkiAbela This study suggests ITU patients with severe pneumonia, who are given early hydrocortisone, have significantly reduced mortality compared to placebo. Not sure how this relates to our ED management but it’s an interesting paper published this year https://t.co/nOPrJ4dUXG
@emeowgencydoc You’ll be interested in this then https://t.co/nOPrJ4dUXG This is the paper I’m presenting tomorrow at our journal club
Answer: True. https://t.co/qFam006SHF
RT @DrYukselUrun: Hydrocortisone in Severe Community-Acquired Pneumonia: promising results in reducing mortality and improving lung functio…
Hydrocortisone in Severe Community-Acquired Pneumonia: promising results in reducing mortality and improving lung function in patients who had been admitted to the intensive care unit. @NEJM #medtwitter @AKINKAYA6 https://t.co/pepZGJclp3
RT @KessnerJp: Hydrocortisone in Severe Community-Acquired Pneumonia. https://t.co/OntsD91nsA
RT @OrlandoRPN: Hidrocortisona en Neumonía Grave (adquirida en la comunidad) logró disminuir la mortalidad ✅ Px que mejoraron al día 4: 20…
RT @OrlandoRPN: Hidrocortisona en Neumonía Grave (adquirida en la comunidad) logró disminuir la mortalidad ✅ Px que mejoraron al día 4: 20…
RT @OrlandoRPN: Hidrocortisona en Neumonía Grave (adquirida en la comunidad) logró disminuir la mortalidad ✅ Px que mejoraron al día 4: 20…
【RCT】重度の市中肺炎でICUに入院した患者へのヒドロコルチゾンの静注は、プラセボの静注と比較して、28日時点の死亡を減少させた。 #ペ読 https://t.co/RXfPJDSzZ9
RT @FlightDocKosuke: NEJMより,重症市中肺炎へのステロイド投与についての多施設RCT(n=795). 肺炎でICU入室した成人(septic shockは除外)を,ステロイド(ヒドロコルチゾン静注200mg/日を4or8日間)投与群とプラセボ群に割付.…
"Hydrocortisone in Severe Community-Acquired Pneumonia" (via #pubmedontap) Appropriate use of hydrocortisone prevents host’ damage associated with common pneumonia. https://t.co/FMw7R2r8So
RT @FlightDocKosuke: NEJMより,重症市中肺炎へのステロイド投与についての多施設RCT(n=795). 肺炎でICU入室した成人(septic shockは除外)を,ステロイド(ヒドロコルチゾン静注200mg/日を4or8日間)投与群とプラセボ群に割付.…
RT @OrlandoRPN: Hidrocortisona en Neumonía Grave (adquirida en la comunidad) logró disminuir la mortalidad ✅ Px que mejoraron al día 4: 20…
RT @CHESTCritCare: Hot off the Presses @NEJM: Hydrocortisone in Severe Community-Acquired Pneumonia New French study by Dequin et al. fin…
RT @CHESTCritCare: Hot off the Presses @NEJM: Hydrocortisone in Severe Community-Acquired Pneumonia New French study by Dequin et al. fin…
RT @FlightDocKosuke: NEJMより,重症市中肺炎へのステロイド投与についての多施設RCT(n=795). 肺炎でICU入室した成人(septic shockは除外)を,ステロイド(ヒドロコルチゾン静注200mg/日を4or8日間)投与群とプラセボ群に割付.…
RT @CHESTCritCare: Hot off the Presses @NEJM: Hydrocortisone in Severe Community-Acquired Pneumonia New French study by Dequin et al. fin…
RT @CHESTCritCare: Hot off the Presses @NEJM: Hydrocortisone in Severe Community-Acquired Pneumonia New French study by Dequin et al. fin…
Hot off the Presses @NEJM: Hydrocortisone in Severe Community-Acquired Pneumonia New French study by Dequin et al. finds reduction in 28 day mortality in the treatment group in a phase 3, double-blind, multicenter, randomized controlled trial. https://t.co/iRa3KKiZlP
RT @FlightDocKosuke: NEJMより,重症市中肺炎へのステロイド投与についての多施設RCT(n=795). 肺炎でICU入室した成人(septic shockは除外)を,ステロイド(ヒドロコルチゾン静注200mg/日を4or8日間)投与群とプラセボ群に割付.…
RT @FlightDocKosuke: NEJMより,重症市中肺炎へのステロイド投与についての多施設RCT(n=795). 肺炎でICU入室した成人(septic shockは除外)を,ステロイド(ヒドロコルチゾン静注200mg/日を4or8日間)投与群とプラセボ群に割付.…
RT @FlightDocKosuke: NEJMより,重症市中肺炎へのステロイド投与についての多施設RCT(n=795). 肺炎でICU入室した成人(septic shockは除外)を,ステロイド(ヒドロコルチゾン静注200mg/日を4or8日間)投与群とプラセボ群に割付.…
NEJMより,重症市中肺炎へのステロイド投与についての多施設RCT(n=795). 肺炎でICU入室した成人(septic shockは除外)を,ステロイド(ヒドロコルチゾン静注200mg/日を4or8日間)投与群とプラセボ群に割付. 28日時点での死亡率はステロイド群の方が有意に低かった(6.2%vs11.9%). https://t.co/cjHwqDnPFz
RT @EARL_med_tw2: ICUに入室した成人重症市中肺炎に対するヒドロコルチゾン(200mg/日→漸減)投与はプラセボに比して28日死亡を有意に改善させた(6.2%vs11.9%).新たに人工呼吸器装着や血管作動薬を要した患者も有意に少なかった.800例DB-RCT…
RT @EARL_med_tw2: ICUに入室した成人重症市中肺炎に対するヒドロコルチゾン(200mg/日→漸減)投与はプラセボに比して28日死亡を有意に改善させた(6.2%vs11.9%).新たに人工呼吸器装着や血管作動薬を要した患者も有意に少なかった.800例DB-RCT…
ICUに入室した成人重症市中肺炎に対するヒドロコルチゾン(200mg/日→漸減)投与はプラセボに比して28日死亡を有意に改善させた(6.2%vs11.9%).新たに人工呼吸器装着や血管作動薬を要した患者も有意に少なかった.800例DB-RCT,PhaseⅢ(N Engl J Med 2023 Mar21) https://t.co/wP5SpMs8Ws
RT @KessnerJp: Hydrocortisone in Severe Community-Acquired Pneumonia. https://t.co/OntsD91nsA
RT @KessnerJp: Hydrocortisone in Severe Community-Acquired Pneumonia. https://t.co/OntsD91nsA
Hydrocortisone in Severe Community-Acquired Pneumonia https://t.co/ycSaevQkPG
NEJM 2023 Mar 21. doi: 10.1056 Hydrocortisone in Severe Community Acquired Pneumonia https://t.co/ztglxgpSq4 Dequin
RT @KessnerJp: Hydrocortisone in Severe Community-Acquired Pneumonia. https://t.co/OntsD91nsA
RT @KessnerJp: Hydrocortisone in Severe Community-Acquired Pneumonia. https://t.co/OntsD91nsA
RT @KessnerJp: Hydrocortisone in Severe Community-Acquired Pneumonia. https://t.co/OntsD91nsA
RT @KessnerJp: Hydrocortisone in Severe Community-Acquired Pneumonia. https://t.co/OntsD91nsA
RT @KessnerJp: Hydrocortisone in Severe Community-Acquired Pneumonia. https://t.co/OntsD91nsA
Hydrocortisone in Severe Community-Acquired Pneumonia. https://t.co/OntsD91nsA